| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/03/2005 | US6887847 Virus derived antimicrobial peptides |
| 05/03/2005 | US6887843 Chlamydia protein, gene sequence and uses thereof |
| 05/03/2005 | US6887680 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays |
| 05/03/2005 | US6887501 Isolated from cocoa beans; solvent extraction; nitric oxide synthase/lipoxygenase/cyclooxygenase modulators |
| 05/03/2005 | US6887487 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 05/03/2005 | US6887483 Non-toxic mutants of pathogenic gram-negative bacteria |
| 05/03/2005 | US6887478 Genetic engineered caspid genes and proteins which which mimic epitopes on human and animal DNA viruses, used for prophylaxis of viral diseases; immunology |
| 05/03/2005 | US6887462 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata) |
| 05/03/2005 | CA2366316C Multi-component vaccine comprising at least three antigens to protect against disease caused by haemophilus influenzae |
| 05/03/2005 | CA2320388C Novel dihydroxyhexanoic acid derivatives |
| 05/03/2005 | CA2236677C 4-pyrimidinyl- or 4-pyrazinyl-piperazinyl-phenyl-oxazolidinone derivatives, their preparation and their use as anti-bacterial agents |
| 05/03/2005 | CA2208704C 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same |
| 05/03/2005 | CA2201477C New pyrimidone derivatives with antifungal activity |
| 05/03/2005 | CA2184598C Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine |
| 05/03/2005 | CA2158999C Crystalline benzathine salt of cefonicid and its preparation |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |
| 04/28/2005 | WO2005037866A2 Igg3 anti rhesus-d in the line yb2/0 having a high phagocytosis activity |
| 04/28/2005 | WO2005037839A1 Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof |
| 04/28/2005 | WO2005037306A1 Combination therapy |
| 04/28/2005 | WO2005037272A1 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors |
| 04/28/2005 | WO2005037187A2 High affinity ligands for influenza virus and methods for their production |
| 04/28/2005 | WO2005014040A3 Antigen delivery system |
| 04/28/2005 | WO2005013955A3 Topical composition comprising terbinafine and hydrocortisone |
| 04/28/2005 | WO2005005398A3 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 04/28/2005 | WO2004098634A3 Protein arginine n-methyltransferase 2 (prmt-2) |
| 04/28/2005 | WO2004032622A3 Production of peptides in plants as viral coat protein fusions |
| 04/28/2005 | WO2004011486A8 Method for solubilizing hydrophobic peptides and use thereof for inducing an antitumoral and/or anti-infectious ctl response |
| 04/28/2005 | WO2003099201A3 Compositions and methods of use for a fibroblast growth factor |
| 04/28/2005 | WO2003095971A3 Posh nucleic acids, polypeptides and related methods |
| 04/28/2005 | US20050090667 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 04/28/2005 | US20050090562 1-benzoyl-8,8-dimethyl-2-hydroxy-3,5,7-tris(3-methyl-2-butenyl)bicyclo- [3.3.]non-2-ene-4,9-dione and a protein kinase inhibitor; antineoplastic agents; antiproliferative agents |
| 04/28/2005 | US20050090546 Compounds such as N,N-dibenzylphenylalanine benzyl ester, used as enzyme inhibitors; prophylaxis of lymphadenopathy associated virus, cancer and malaria |
| 04/28/2005 | US20050090536 Substituted pyrrol-3-ylisoxazoles, e.g., N-benzyl-4-[4-(o-chlorophenyl)-5-isoxazolyl)pyrrole-2-carboxamide; treating diseases that are alleviated by a protein kinase inhibitor, particularly cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 04/28/2005 | US20050090525 carboxymethylated N-(nitrogen group functionalized alkyl- carbonylhydrazido)- or carbonylaminomethylcarbonyl)- substituted; integrin inhibitors used for combating thromboses, cardiac infarction, coronary heart diseases, arteriosclerosis, inflammation, tumors, osteoporosis, infections and restenosis |
| 04/28/2005 | US20050090524 Novel adamantane derivatives |
| 04/28/2005 | US20050090521 Tetrazoloquinoline, triazoloquinoline, and oxazoloquinoline compounds, e.g., 9-chloro-N-isopropoxytetrazolo[1,5-a]quinoline-4-carboxamide |
| 04/28/2005 | US20050090516 Novel substituted imides |
| 04/28/2005 | US20050090502 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents |
| 04/28/2005 | US20050090497 Novel ester or amide derivatives |
| 04/28/2005 | US20050090491 2'-Methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/28/2005 | US20050090489 An alpha hydroxy acid or a retinoid as a bacterial fermentation product of a novel Streptomyces strain; topical antiwrinkle agents |
| 04/28/2005 | US20050090482 Potentiators of antibacterial activity |
| 04/28/2005 | US20050090471 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 04/28/2005 | US20050090461 Synthesizing polyketide fusion protein comprising acyltransferase domain for use as anthelminthic, insecticide, antitumor, immunosuppressant, fungicidal and/or bactericidal agents |
| 04/28/2005 | US20050090459 Crystal forms of azithromycin |
| 04/28/2005 | US20050090452 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae |
| 04/28/2005 | US20050090433 Dalbavancin compositions for treatment of bacterial infections |
| 04/28/2005 | US20050089985 Rescue of canine distemper virus from cdna |
| 04/28/2005 | US20050089984 Having a specific amino acid sequence, especially fused to a heterologous polypeptide; induces apoptosis |
| 04/28/2005 | US20050089968 Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin |
| 04/28/2005 | US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 04/28/2005 | US20050089892 Biiodrugs for diagnosis, drug screening, clinical trial monitoring, treatment of physiological disorders; viral disease and infection prevention; expression vectors |
| 04/28/2005 | US20050089884 Genes coding for ketosynthase, acyl transferase, acyl carrier protein, ketoreductase, dehydratase and enoyl reductase domains, and genes coding for modifier enzymes, such as ABC transporter, cytochrome P450 monooxygenase, ferredoxin, thioesterase, 4-amino-4-deoxychorismate (ADC) synthase or lyase |
| 04/28/2005 | US20050089843 Polyclonal antibody specific for mannose-terminated viral envelope protein for use in detection and prevention of viral diseases |
| 04/28/2005 | US20050089839 Assay |
| 04/28/2005 | US20050089545 Drug delivery system for the subconjunctival administration of fine grains |
| 04/28/2005 | US20050089531 Two types of foreign genes inserted in such a manner as to allow the expression into two different regions in the recombinant feline herpesvirus type 1 genome |
| 04/28/2005 | US20050089526 Monomeric unit of the complex containin HIV-1 gp120 and HIV-1 gp41, (ii) the gp4l has one or more mutations in its N-terminal helix, and (iii) the gp120 and gp41 are bound to each other by a disulfide bond between a cysteine residue introduced into the gp120 and a cysteine residue introduced into gp41 |
| 04/28/2005 | US20050089520 Antibody stimulating il-ira production |
| 04/28/2005 | US20050089514 Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections |
| 04/28/2005 | US20050089506 Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby |
| 04/28/2005 | US20050089479 Delivery of sedative-hypnotics through an inhalation route |
| 04/28/2005 | US20050087198 Method for systemic drug delivery through the nail |
| 04/28/2005 | CA2543447A1 Antibody and use of the same |
| 04/28/2005 | CA2542662A1 Pharmaceutical combinations comprising il-21 |
| 04/28/2005 | CA2542508A1 Novel igg3 antibodies for stimulating phagocytosis |
| 04/28/2005 | CA2542128A1 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| 04/28/2005 | CA2541857A1 Combination therapy for hcv infection |
| 04/28/2005 | CA2536082A1 Therapeutic uses of chemokine variants |
| 04/28/2005 | CA2526691A1 High throughput screening of aptamer libraries for specific binding to proteins on viruses and other pathogens |
| 04/27/2005 | EP1526183A2 Dimer of a peptide derived from the C-terminal sequence of human superoxide dismutase facilitating the penetration of a substance into cells and/or cell nuclei |
| 04/27/2005 | EP1526134A2 Triazolyl tropane derivatives as ccr5 modulators |
| 04/27/2005 | EP1525889A1 Liquid pharmaceutical composition containing an erythropoietin derivative |
| 04/27/2005 | EP1525883A1 Ciclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/27/2005 | EP1525797A2 Synergistic microbicidal combination |
| 04/27/2005 | EP1525313A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 04/27/2005 | EP1525312A2 Brachyspira hyodysenteriae vaccine |
| 04/27/2005 | EP1525306A1 Three-dimensional structure of dipeptidyl peptidase iv |
| 04/27/2005 | EP1525223A2 Ox40 (=cd134) receptor agonists and therapeutic use |
| 04/27/2005 | EP1525217A1 Plant peptide with antimicrobial activity |
| 04/27/2005 | EP1525209A2 1'-, 2'- and 3' -modified nucleoside derivatives for treating flaviviridae infections |
| 04/27/2005 | EP1525208A2 Novel difluorinated gem compounds, preparation methods thereof and applications of same |
| 04/27/2005 | EP1525205A2 Novel substituted pyrazolo( 1,5-a /i ]-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same |
| 04/27/2005 | EP1525201A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 04/27/2005 | EP1525199A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525018A1 Medicament dispenser |
| 04/27/2005 | EP1525000A2 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 04/27/2005 | EP1524997A1 Stable liquid parenteral parecoxib formulation |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1524966A1 Taste masked oral composition of telithromycin |
| 04/27/2005 | EP1524965A2 Stabilization of the profile of release of active substances from a formulation |
| 04/27/2005 | EP1419150B1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 04/27/2005 | EP1370513B1 Malic acid addition salts of terbinafine |
| 04/27/2005 | EP1358320A4 68730 and 69112 protein kinase molecules and uses therefor |
| 04/27/2005 | EP1150713B1 Vaccine formulation comprising monoglycerides or fatty acids as adjuvant |
| 04/27/2005 | EP1150707B1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 04/27/2005 | EP1056458B1 Treatment of chronic pain |
| 04/27/2005 | EP1040098B1 Integrin receptor antagonists |